BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...
Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design, that could help to create better images which help doctors diagnose patients' conditions more ...
Techniques that exploit the phase of X-rays, not just their absorption, have the potential to transform X-ray imaging in hospitals, reports Jude Dineley Improved imaging Marian Willner from the ...
Morning Overview on MSN
New imaging breakthrough makes cancer cells light up on cue
Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical ...
92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent ...
Magnetic Resonance Imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated for its non-ionizing and non-invasive nature. With nearly 40% of MRI procedures requiring contrast ...
Envisioning pathological processes in the central nervous system using preclinical MRI Magnetic resonance imaging (MRI) is a well-known means of imaging for clinically managing patients with ...
Magnetic resonance imaging (MRI) machines can clearly view non-bony parts of the body—soft tissue such as the brain, muscles and ligaments—as well as detect tumors, making it possible to diagnose many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback